Global Immunochemicals Industry

Global Immunochemicals Industry

  • April 2021 •
  • 200 pages •
  • Report ID: 5205334 •
  • Format: PDF
Abstract:
- Global Immunochemicals Market to Reach $5.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Immunochemicals estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at aCAGR of 5.3% over the period 2020-2027. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 5% CAGR
- The Immunochemicals market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$929.7 Million by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

- Select Competitors (Total 116 Featured) -
  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.